Applying Nuclear Regulatory Commission guidelines to the release of patients treated with sodium iodine-131.
This article presents a brief synopsis of the 1997 regulations from the Nuclear Regulatory Commission concerning the release from the hospital of patients treated for thyroid disease with 131I. A simplified checklist is provided to demonstrate the instructions to patients and the new conditions for release of patients containing a higher level of 131I radioactivity than was allowed under the older regulations.
Tuttle
W K
WK
VA Medical Center and Department of Diagnostic Radiology, Oregon Health Sciences University, Portland, USA. william.tuttle@med.va.gov
Brown
P H
PH
D006077:Government Agencies; D019983:Guideline Adherence; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D010351:Patient Discharge; D017410:Practice Guidelines as Topic; D013964:Thyroid Neoplasms / Q000532:radiotherapy*; D014481:United States
D007457:Iodine Radioisotopes